Abstract
There is a close connection throughout the lifespan between attention deficit/hyperactivity disorder (ADHD) and an increased risk of cardiometabolic diseases, such as obesity, diabetes mellitus and arterial hypertension. According to current knowledge, the causes are genetic factors, dopamine metabolism disorders, circadian rhythm disorders, inflammatory processes and, last but not least, an unhealthy lifestyle. The treatment of individuals with ADHD and comorbid cardiometabolic diseases requires an individualized approach with lifestyle changes, psychotherapy and pharmacotherapy, taking possible cardiometabolic side effects of the ADHD medication into account.
| Translated title of the contribution | Attention deficit/hyperactivity disorder and cardiometabolic diseases: prevalence, etiology and treatment |
|---|---|
| Original language | German |
| Pages (from-to) | 309-317 |
| Number of pages | 9 |
| Journal | Der Nervenarzt |
| Volume | 96 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - May 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cardiovascular diseases
- Genetics
- Lifestyle
- Metabolic diseases
- Obesity
Fingerprint
Dive into the research topics of 'Attention deficit/hyperactivity disorder and cardiometabolic diseases: prevalence, etiology and treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver